Sign In
Buy TBPH
$16.90
-0.0300 (-0.177%)
At Close: Jul 13, 2026
Theravance Biopharma To Present at the 39th Annual J.P. Morgan Healthcare Conference
06:00am, Tuesday, 05'th Jan 2021
DUBLIN, Jan. 5, 2021 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development, and commercialization of organ-
Theravance Biopharma Is A Buy
01:16pm, Wednesday, 02'nd Dec 2020
Today, we revisit Theravance Biopharma for the first time in over a year. The stock has had a challenging year in 2020, but there are some potentially significant catalysts on the horizon in 2021.
Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q3 2020 Results - Earnings Call Transcript
01:24pm, Sunday, 08'th Nov 2020
Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q3 2020 Results - Earnings Call Transcript
